<Anchor>



This week, vaccination in Korea is also starting.

This Friday, at 9 am, the Pfizer vaccine will also begin on Saturday, starting with the AstraZeneca vaccine.

The government has set a goal of forming population immunity by November through vaccination, but there are many variables before reaching this goal.



Reporter Nam Joo-hyun will explain the vaccination schedule and the variables for the formation of group immunity.



<Reporter>



About 40% of 750,000 AstraZeneca vaccines shipped in Korea for the first time tomorrow (24th) will be delivered to public health centers and nursing hospitals nationwide from the 25th to the 28th.



Starting with the first vaccination at 9 am on the 26th, 289,000 people, including nursing hospital workers and residents, are in turn.



From the 8th of next month, about 350,000 medical staff at advanced general hospitals, general hospitals and hospital-level medical institutions will also receive the AstraZeneca vaccine.



The 59,000 Pfizer vaccines received through COVAX Facility will be vaccinated immediately after arrival at the Central Vaccination Center.



The vaccine, which will be vaccinated this week, is about 809,000 people, and 1.6% of Koreans can get it, and there is no set amount for additional introduction.



The Korea Centers for Disease Control and Prevention (KCDC) believes that when the inoculation rate exceeds 70%, 56% of the people can achieve collective immunity by possessing antibodies, assuming an epidemic with an infection reproduction index of about 2.



In order to achieve the target population immunity for November, it is important to secure the vaccine in time and raise the vaccination rate by more than 70%, but there is another variable.



[Eun-Kyung Jung/Director of the Korean Disease Control Center: How much mutant virus occurs, how much it affects the vaccine, etc. are important variables in achieving collective immunity.] The



Economist Intelligent Unit, an economic analysis agency in the UK, is an Asian country such as Korea. It is expected to form collective immunity by the middle of next year.